Clinical Trial Update: Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated combining panretinal photocoagulation with ranibizumab for proliferative diabetic retinopathy and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Proliferative Diabetic Retinopathy

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: University of Sao Paulo | Conditions: Diabetic Retinopathy, Retinal Neovascularization | Phase 2 | Status: COMPLETED